Axogen Presents Prostate Nerve Reconstruction Market Launch Plans

• Axogen is moving forward with a prostate nerve reconstruction market launch using Avance nerve grafts.
• The presentation estimates a $754 million total addressable market, with a weighted average selling price of approximately $7,000 per procedure.
• Clinical experience includes more than 220 reconstructed patients across 15 sites; 117 patients had at least six months of follow-up.
• At six months, approximately 80% had better-than-expected erectile function; more than 95% had regained continence.
• A hospital administrator survey found 56% would support adoption before broad insurance coverage.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Axogen Inc. published the original content used to generate this news brief on November 09, 2026, and is solely responsible for the information contained therein.